Related Experiment Video

Updated: Mar 20, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.4K

Modern management of adult coarctation: transcatheter and surgical options

Heiko Schneider1, Anselm Uebing, Darryl F Shore

  • 1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK - a.uebing@rbht.nhs.uk.

The Journal of Cardiovascular Surgery
|June 1, 2016
PubMed

Insights

Transcatheter interventions are now the primary choice for adult coarctation of the aorta (CoA) treatment. Complex cases may still require surgical repair, with ongoing advancements in both approaches.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Thoracic Surgery

Background:

  • Coarctation of the aorta (CoA) is a congenital heart defect affecting 5-8% of patients with congenital heart disease.
  • Surgical and transcatheter treatments for CoA have evolved significantly since the 1950s.

Purpose of the Study:

  • To review current endovascular and surgical practices for coarctation of the aorta.
  • To highlight modern developments and limitations in CoA treatment.

Main Methods:

  • Review of current endovascular techniques for native and recurrent coarctation of the aorta.
  • Analysis of surgical approaches for complex aortic arch anatomy and aneurysms.
  • Discussion of treatment strategies for recurrent coarctation and associated aneurysms.

Main Results:

  • Transcatheter options are the preferred initial treatment for adult patients with native or recurrent CoA.
  • Surgical techniques remain essential for complex cases, including extensive arch hypoplasia, stenosis, or para-CoA aneurysms.
  • Stent implantation for aneurysms may necessitate preparatory vascular surgery; bypass conduits are used for complex re-CoA.

Conclusions:

  • Transcatheter interventions represent the current standard of care for most adult CoA cases.
  • Surgical management is reserved for intricate anatomical presentations of coarctation of the aorta.
  • Ongoing advancements continue to refine both endovascular and surgical treatment paradigms for CoA.

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.2K
O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy09:24

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

Published on: October 6, 2022

4.4K

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
440
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
544
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
391
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
539
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569